Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ALNYLAM PHARMACEUTICALS, INC.Financial_Report.xls
10-Q - FORM 10-Q - ALNYLAM PHARMACEUTICALS, INC.b86736e10vq.htm
EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC.b86736exv31w1.htm
EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC.b86736exv32w1.htm
EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC.b86736exv31w2.htm
EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC.b86736exv32w2.htm
Exhibit 12
STATEMENT REGARDING COMPUTATION OF CONSOLIDATED RATIOS OF EARNINGS/DEFICIENCIES TO FIXED CHARGES
(dollars in thousands)
                                                         
    Six Months Ended     Three Months Ended     Fiscal Year Ended December 31,  
    June 30,     June 30,                                
    2011     2011     2010     2009     2008     2007     2006  
Earnings (loss):
                                                       
Pre-tax loss from continuing operations before adjustment for loss from equity investee
  $ (28,025 )   $ (12,812 )   $ (35,362 )   $ (42,098 )   $ (16,240 )   $ (79,146 )   $ (34,608 )
add: Fixed charges (see below)
    603       302       1,207       712       1,115       1,553       1,532  
 
                                         
Pre-tax income (loss) from continuing operations before adjustment for income/loss from equity investees plus fixed charges
  $ (27,422 )   $ (12,510 )   $ (34,155 )   $ (41,386 )   $ (15,125 )   $ (77,593 )   $ (33,076 )
 
                                                       
Fixed charges:
                                                       
Interest expense on indebtedness
  $     $     $     $     $ 872     $ 1,083     $ 1,029  
Interest expense on portion of rent expense representative of interest
    603       302       1,207       712       243       470       503  
 
                                         
Total fixed charges
  $ 603     $ 302     $ 1,207     $ 712     $ 1,115     $ 1,553     $ 1,532  
 
                                         
Ratio of earnings to fixed charges
                                         
 
                                         
Deficiency of earnings available to cover fixed charges
  $ (28,025 )   $ (12,812 )   $ (35,362 )   $ (42,098 )   $ (16,240 )   $ (79,146 )   $ (34,608 )